U.S. markets close in 2 hours 6 minutes

Pfizer Inc. (PFE)

NYSE - Nasdaq Precio en tiempo real. Divisa en USD.
Añadir a la lista de seguimiento
28.06+0.27 (+0.99%)
A partir del 01:54PM EDT. Mercado abierto.

Pfizer Inc.

66 Hudson Boulevard East
New York, NY 10001-2192
United States
212 733 2323
https://www.pfizer.com

Sector(es)Healthcare
IndustriaDrug Manufacturers - General
Empleados a tiempo completo88,000

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Dr. Albert Bourla D.V.M., Ph.D.Chairman of the Board & CEO4.05MN/D1962
Mr. David M. DentonChief Financial Officer & Executive VP1.75MN/D1965
Dr. Mikael Dolsten M.D., Ph.D.Chief Scientific Officer and President of Research & Development2.41MN/D1958
Mr. Douglas M. LanklerExecutive VP & General Counsel1.76MN/D1966
Mr. Aamir MalikExecutive VP & Chief U.S. Commercial Officer1.89MN/D1976
Ms. Jennifer B. DamicoSenior VP, Controller & Principal Accounting OfficerN/DN/D1968
Ms. Lidia L. FonsecaExecutive VP and Chief Digital & Technology OfficerN/DN/D1969
Ms. Francesca M. DeMartinoChief Investor Relations OfficerN/DN/DN/D
Mr. Rady A. JohnsonExecutive VP and Chief Compliance, Quality & Risk OfficerN/DN/D1962
Mr. Andreas J. PanayiotouGlobal Chief Marketing OfficerN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Gestión corporativa

La calificación ISS Governance QuickScore de Pfizer Inc. a partir del 1 de marzo de 2024 es 5. Las puntuaciones principales son Auditoría: 10; Junta: 6; Derechos del accionista: 1; Compensación: 3.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.